 |
|
CLINICIAN'S CORNER
The Incidentalome
A Threat to Genomic Medicine
Isaac S. Kohane, MD, PhD;
Daniel R. Masys, MD;
Russ B. Altman, MD, PhD
JAMA. 2006;296:212-215.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Genomic medicine is poised to offer a broad array of new genome-scale screening tests. However, these tests may lead to a phenomenon in which multiple abnormal genomic findings are discovered, analogous to the "incidentalomas" that are often discovered in radiological studies. If practitioners pursue these unexpected genomic findings without thought, there may be disastrous consequences. First, physicians will be overwhelmed by the complexity of pursuing unexpected genomic measurements. Second, patients will be subjected to unnecessary follow-up tests, causing additional morbidity. Third, the cost of genomic medicine will increase substantially with little benefit to patients or physicians (but with great financial benefits to the genomic testing industry), thus throwing the overall societal benefit of genome-based medicine into question. In this article, we discuss the basis for these concerns and suggest several steps that can be . . . [Full Text of this Article]Diagnostic Testing and Incidental Findings
Author Affiliations: Center of Biomedical Informatics and Division of Health Sciences Technology, Harvard Medical School, Boston, Mass (Dr Kohane); Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tenn (Dr Masys); and Department of Genetics, Stanford University, Stanford, agCalif (Dr Altman).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED LETTERS
The Incidentalome
Susan M. Wolf, Jeffrey P. Kahn, Frances P. Lawrenz, and Charles A. Nelson
JAMA. 2006;296(23):2800-2801.
EXTRACT
| FULL TEXT
The Incidentalome
Michael Kruer
JAMA. 2006;296(23):2801.
EXTRACT
| FULL TEXT
The Incidentalome—Reply
Isaac S. Kohane, Daniel R. Masys, and Russ B. Altman
JAMA. 2006;296(23):2801-2802.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
From Genetics to Genomics: Ethics, Policy, and Parental Decision-making
Wilfond and Ross
J Pediatr Psychol 2009;34:639-647.
ABSTRACT
| FULL TEXT
The Genetic Privacy of Presidential Candidates
Green and Annas
NEJM 2008;359:2192-2193.
FULL TEXT
Keeping Up With the Next Generation: Massively Parallel Sequencing in Clinical Diagnostics
ten Bosch and Grody
J. Mol. Diagn. 2008;10:484-492.
ABSTRACT
| FULL TEXT
Managing incidental findings in human subjects research: analysis and recommendations.
Wolf et al.
J Law Med Ethics 2008;36:219-248.
Genomic research and incidental findings.
Van Ness
J Law Med Ethics 2008;36:292-297.
Ethical, Legal, and Social Concerns About Expanded Newborn Screening: Fragile X Syndrome as a Prototype for Emerging Issues
Bailey et al.
Pediatrics 2008;121:e693-e704.
ABSTRACT
| FULL TEXT
Preemptive Public Policy for Genomics
Carlson
Journal of Health Politics, Policy and Law 2008;33:39-51.
ABSTRACT
Health Care in the Age of Genetic Medicine
Evans
JAMA 2007;298:2670-2672.
FULL TEXT
Personalized Medicine in the Era of Genomics
Burke and Psaty
JAMA 2007;298:1682-1684.
FULL TEXT
The Current Revolution in Newborn Screening: New Technology, Old Controversies
Tarini
Arch Pediatr Adolesc Med 2007;161:767-772.
ABSTRACT
| FULL TEXT
The Genomics Gold Rush
Topol et al.
JAMA 2007;298:218-221.
FULL TEXT
Personalized Medicine for High Blood Pressure
Turner et al.
Hypertension 2007;50:1-5.
FULL TEXT
The Incidentalome
Kruer
JAMA 2006;296:2801-2801.
FULL TEXT
The Incidentalome
Wolf et al.
JAMA 2006;296:2800-2801.
FULL TEXT
|
